Max Robotics — Global Service Robot Directory + US Certification

About

Kei Ishibashi is a urological surgeon and researcher whose work centers on robot-assisted radical prostatectomy (RARP) and the pathophysiology of benign prostatic enlargement. He has made significant contributions to understanding and improving urinary continence outcomes following minimally invasive prostate cancer surgery, a complication that remains one of the most challenging aspects of postoperative recovery for patients. Ishibashi's most influential work, cited 119 times, examines the pathophysiology of post-prostatectomy urinary incontinence and intraoperative techniques to optimize surgical outcomes, establishing him as a leading voice in refining RARP methodology. His subsequent studies have explored how pelvic anatomical features, nerve-sparing procedures, and suturing techniques influence continence recovery, offering actionable guidance for surgeons worldwide. Notably, his research extended beyond surgical technique to patient quality of life, demonstrating that even practical factors such as urinary pad exchange timing meaningfully affect postoperative well-being. Beyond prostate cancer surgery, Ishibashi has pioneered investigation into the vascular origins of benign prostatic enlargement, linking local arterial atherosclerosis and chronic ischemia to prostatic growth — a compelling mechanistic insight with implications for prevention and treatment. With over 280 cumulative citations, his body of work reflects both clinical rigor and a genuine commitment to improving patients' lived experience following prostate surgery.